This City Councilman Turned a $50K Deal Into a Personal Payday. Now He's...
Meet the Conservative Outsider Who Wants to Bring Common Sense Back to His...
How This Small-Town Police Force Became a 'Criminal Organization'
Iranian Regime's Latest Move Shows How Desperate It Has Become
CBS News Tried to Recalibrate Detention Stats — DHS Was Having None of...
If 'The Only Thing More Powerful Than Hate Is Love' Democrats Missed the...
Elites Did Their Part to Fight Global Warming by Flying Dozens of Private...
Man Who Pushed Propaganda About a Young Gazan Boy Slaughtered By The IDF...
Harry Sisson Refuses to House Illegals in His Home, And Claims ICE Agent...
Critics Blast Katie Porter's Pre Super Bowl X Post As She Tries to...
Will We Reach 100 Days of Straight Liberal Content on the Apple News...
Immigration Win: Federal Court Sides With Trump Admin on TPS Terminations for Multiple...
Federal Judge Blocks California Effort to Demask ICE Agents
Jasmine Crockett Might Be Running the Most Incompetent Campaign in History
WaPo Claims That Bad Bunny's Profane Performance Represented 'Wholesome Family Values'
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos